SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-21-011419
Filing Date
2021-11-22
Accepted
2021-11-22 17:00:59
Documents
13
Period of Report
2021-11-22
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT admp-8k_112221.htm   iXBRL 8-K 25241
2 PRESS RELEASE ex99-1.htm EX-99.1 26974
  Complete submission text file 0001387131-21-011419.txt   231076

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE admp-20211122.xsd EX-101.SCH 3001
4 XBRL LABEL FILE admp-20211122_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE admp-20211122_pre.xml EX-101.PRE 22343
6 EXTRACTED XBRL INSTANCE DOCUMENT admp-8k_112221_htm.xml XML 3589
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36242 | Film No.: 211433340
SIC: 2834 Pharmaceutical Preparations